Bleeding complications following CT-guided percutaneous native kidney biopsy with DDAVP (1-deamino-8-D-arginine vasopressin) pre-treatment [PDF]
, 2016 P. O’Connor +4 more
openalex +2 more sources
DDAVP (desmopressin; 1‐deamino‐cys‐8‐
British Journal of Haematology, 2000 Stephan Ehl, Thomas Severin, A. H. Sutor
openalex +2 more sources
A retrospective study of the utility of desmopressin (1‐deamino‐8‐
International Journal of Laboratory Hematology, 2009 Jake Shortt +5 more
openalex +2 more sources
Korean guideline of desmopressin for the treatment of nocturia in men [PDF]
Investigative and Clinical Urology, 2022 Purpose: Nocturia is the most bothersome of lower urinary tract symptoms in men. Desmopressin, a synthetic analog of the human hormone vasopressin, has been used for the treatment of nocturia.
Eu Chang Hwang +9 more
doaj +1 more source
Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial [PDF]
Investigative and Clinical Urology, 2021 Purpose: To assess the efficacy of desmopressin plus anticholinergic combination therapy as first-line treatment for children with primary monosymptomatic nocturnal enuresis (PMNE) and to analyze this combination's effect on functional bladder capacity ...
Myungsun Shim +4 more
doaj +1 more source
Idiopathic partial central diabetes insipidus
Einstein (São Paulo), 2023 Diabetes insipidus is a rare disorder characterized by the inability to concentrate urine, which results in hypotonic urine and increased urinary volume.
Larissa Fabre, Viviane Calice da Silva
doaj +1 more source
Otorhinolaryngological adverse effects of urological drugs
International Brazilian Journal of Urology, 2021 Purpose: To describe the otorhinolaryngological adverse effects of the main drugs used in urological practice. Materials and Methods: A review of the scientific literature was performed using a combination of specific descriptors (side effect, adverse ...
Nathalia de Paula Doyle Maia +2 more
doaj +1 more source
Haemophilia, Volume 29, Issue 4, Page 1095-1103, July 2023., 2023 Abstract Introduction Peri‐procedural management of von Willebrand disease (VWD) utilizes von Willebrand factor (VWF) concentrates or desmopressin (DDAVP) to increase VWF levels. DDAVP is safe, easily administered, and inexpensive. Currently, a consensus definition for adequate DDAVP response is lacking, and outcomes of peri‐procedural DDAVP use in VWD
Priya Chandrakumaran +2 more
wiley +1 more source
Clotting Factor XIII and desmopressin improve hemostasis in uncontrolled bleeding [PDF]
Acta Cirúrgica Brasileira, 2015 PURPOSE: To investigate hemostatic effects of supplementary factor XIII and desmopressin (DDAVP) in resuscitation of uncontrolled bleeding.METHODS:Fifty-four rabbits were randomized in nine groups: G1: Sham; G2: FXIII and normotensive resuscitation (NBP);
Paulo Roberto Lima Carreiro +7 more
doaj +1 more source
Depression and anxiety in persons with Von Willebrand disease
Haemophilia, Volume 29, Issue 2, Page 545-554, March 2023., 2023 Abstract Objective We assessed sociodemographic and clinical characteristics associated with depression and anxiety in individuals with Von Willebrand disease (VWD) aged ≥12 years. Methods The study collected data on patients’ sociodemographic, joint problems and health‐related quality of life (HRQoL) using EQ‐5D‐3L, 8‐item patient health questionnaire
Jonathan C. Roberts +11 more
wiley +1 more source